HUE042620T2 - Rekonstituált HDL-készítmény - Google Patents

Rekonstituált HDL-készítmény

Info

Publication number
HUE042620T2
HUE042620T2 HUE13851610A HUE13851610A HUE042620T2 HU E042620 T2 HUE042620 T2 HU E042620T2 HU E13851610 A HUE13851610 A HU E13851610A HU E13851610 A HUE13851610 A HU E13851610A HU E042620 T2 HUE042620 T2 HU E042620T2
Authority
HU
Hungary
Prior art keywords
reconstituted hdl
hdl formulation
formulation
reconstituted
hdl
Prior art date
Application number
HUE13851610A
Other languages
English (en)
Inventor
Yvonne Vucica
Gary Lee Warren
Original Assignee
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/803,863 external-priority patent/US9125943B2/en
Application filed by Csl Ltd filed Critical Csl Ltd
Publication of HUE042620T2 publication Critical patent/HUE042620T2/hu

Links

HUE13851610A 2012-11-02 2013-10-31 Rekonstituált HDL-készítmény HUE042620T2 (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261721771P 2012-11-02 2012-11-02
EP13153903 2013-02-04
US13/803,863 US9125943B2 (en) 2012-11-02 2013-03-14 Reconstituted HDL formulation
AU2013205684A AU2013205684B2 (en) 2012-11-02 2013-04-10 Reconstituted hdl formulation

Publications (1)

Publication Number Publication Date
HUE042620T2 true HUE042620T2 (hu) 2019-07-29

Family

ID=66094127

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13851610A HUE042620T2 (hu) 2012-11-02 2013-10-31 Rekonstituált HDL-készítmény

Country Status (4)

Country Link
DK (1) DK2916857T3 (hu)
ES (1) ES2719275T3 (hu)
HU (1) HUE042620T2 (hu)
TR (1) TR201905244T4 (hu)

Also Published As

Publication number Publication date
ES2719275T3 (es) 2019-07-09
TR201905244T4 (tr) 2019-05-21
DK2916857T3 (en) 2019-04-15

Similar Documents

Publication Publication Date Title
HK1203146A1 (en) Antibody formulation
ZA201500212B (en) Progesterone formulations
PL3117837T3 (pl) Formulacje przeciwciała
PL2802209T3 (pl) Preparaty do uszu
GB201111438D0 (en) Formulation
ZA201309221B (en) Formulation
HK1212599A1 (zh) 重構的 配製劑
HK1202445A1 (en) New formulation
ZA201306000B (en) Stable formulation
HK1205679A1 (en) Nicotine formulation
ZA201402456B (en) Formulation
PL2662093T3 (pl) Preparat tobramycyny
EP2800474A4 (en) COFFEE FORMULATION
GB201106958D0 (en) Formulation
HUE042620T2 (hu) Rekonstituált HDL-készítmény
IL234771B (en) Nicotine formulation
GB201211247D0 (en) Improved formulation
GB201206178D0 (en) Formulations
SI2662093T1 (sl) Formulacija tobramicina
GB201104284D0 (en) Formulation